Compliance with inhaled insulin treatment using the AERx® iDMS insulin diabetes management system

Diabetes Technology and Therapeutics

Volumn 6, Issue 6, 2004, Pages 800-807

  Cramer, J A ^a   Okikawa, J ^b   Bellaire, S ^c   Clauson, P ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Aradigm   (United States)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; GLUCOSE BLOOD LEVEL; HOME MONITORING; HUMAN; INTERMETHOD COMPARISON; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME;

EID: 12344317702     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2004.6.800     Document Type: Article

References (24)

1. Farr SJ, McElduff A, Mather LE, Okikawa J, Ward ME, Gonda I, Licko V, Rubsamen RM: Pulmonary insulin administration using the AERx® system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects. Diabetes Technol Ther 2000;2:185-197.
2. Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U: Intensive therapy with inhaled insulin via the AERx insulin diabetes management system. Diabetes Care 2004;27:162-167.
3. Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, Okikawa J, Fieber TR: Dose-response relation of liquid aerosol inhaled insulin in Type 1 diabetic patients. Diabetologia 2001;44:305-308.
4. Cramer JA: A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-1224.
5. Cramer JA: Medication use by the elderly: enhancing patient compliance in the elderly: role of packaging aids and monitoring. Drugs Aging 1998;12:7-15.
6. Gonda I, Schuster JA, Rubsamen RM, Lloyd P, Cipolla D, Farr SJ: Inhalation delivery systems with compliance and disease management capabilities. J Controlled Release 1998;53:269-274.
7. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C: Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-1057.
8. Matsuyama JR, Mason BJ, Jue SG: Pharmacists' interventions using electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother 1993;27:851-855.
9. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS: Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993;104:501-507.
10. Claxton AJ, Cramer JA, Pierce C: Medication compliance: the importance of the dosing regimen. Clin Ther 2001;23:1296-1310.
11. Johnson SB: Methodological issues in diabetes research: measuring adherence. Diabetes Care 1992;15:1658-1667.
12. Morris AD, Boyle DIR, McMahon AD, Greene SA, MacDonald TM, Newton RW, for the DARTS/MEMO Collaboration: Adherence to insulin treatment, glycemie control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997;350:1505-1510.
13. Rajagopalan R, Joyce A, Smith D, Ollendorf D, Murray FT: Medication compliance in type 2 diabetes patients: retrospective data analysis [abstract]. Value Health 2003;6:328.
14. Cramer JA: The relationship between medication compliance and medical outcomes. Am J Health Systems Pharm 1995;52(Suppl 3):S27-S29.
15. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
16. United Kingdom Prospective Diabetes Study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995;310:83-88.
17. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab 1987;65:30-36.
18. Larsen DL, Cannon W, Towner S: Longitudinal assessment of a diabetes care management system in an integrated health network. J Managed Care Pharm 2003;9:552-558.
19. Fain JA, Nettles A, Funnell MM, Charron D: Diabetes patient education research: an integrative literature review. Diabetes Educ 1999;25:7-15.
20. Peyrot M, Mathews DR, Snoek FJ, Skovlund S: An international study of psychological resistance to insulin use among persons with diabetes [abstract]. Diabetologia 2003;46(Suppl 2):A89.
21. Skovlund SE, van der Ven N, Pouwer F, Snoek F: Appraisal of insulin treatment among Type 2 diabetes patients with and without previous experience of insulin therapy [abstract]. Diabetologia 2003;46(Suppl 2):A89.
22. Cramer JA: Partial medication compliance: the enigma in poor medical outcomes. Am J Managed Care 1995;1:45-52.
23. Cramer JA: Effect of partial compliance on cardiovascular medication effectiveness. Heart 2002;88:203-206.
24. World Health Organization: Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.